|
|
||||||||
-lipoic acid on skeletal muscle
contractile properties
1 Center for Exercise Science, University of Florida, Gainesville, Florida 32611; 2 Department of Molecular and Cell Biology, University of California, Berkeley, California 94720; and 3 Department of Physiology, University of Kuopio, Kuopio, Finland 70211
| |
ABSTRACT |
|---|
|
|
|---|
Initial experiments were conducted using an in situ
rat tibialis anterior (TA) muscle preparation to assess the influence of dietary antioxidants on muscle contractile properties. Adult Sprague-Dawley rats were divided into two dietary groups: 1)
control diet (Con) and 2) supplemented with vitamin E (VE)
and
-lipoic acid (
-LA) (Antiox). Antiox rats were fed the Con
rats' diet (AIN-93M) with an additional 10,000 IU VE/kg diet and 1.65 g/kg
-LA. After an 8-wk feeding period, no differences existed
(P > 0.05) between the two dietary groups in maximum
specific tension before or after a fatigue protocol or in force
production during the fatigue protocol. However, in unfatigued muscle,
maximal twitch tension and tetanic force production at stimulation
frequencies
40 Hz were less (P < 0.05) in Antiox
animals compared with Con. To investigate which antioxidant was
responsible for the depressed force production, a second experiment was
conducted using an in vitro rat diaphragm preparation. Varying
concentrations of VE and dihydrolipoic acid, the reduced form of
-LA, were added either individually or in combination to baths
containing diaphragm muscle strips. The results from these experiments
indicate that high levels of VE depress skeletal muscle force
production at low stimulation frequencies.
antioxidants; contraction; redox; oxidation; reactive oxygen species
| |
INTRODUCTION |
|---|
|
|
|---|
IT WAS RECOGNIZED OVER A DECADE AGO that the redox status of skeletal muscle fibers is altered by heavy exercise (8). Indeed, exercising muscle produces reactive oxygen species (ROS) such as superoxide anions and hydroxyl radicals (10). Furthermore, it is now clear that intense muscular contractile activity can result in oxidative stress as indicated by altered muscle glutathione levels and an increase in both protein oxidation and lipid peroxidation (2, 8, 15, 26, 32). When proteins and lipids become oxidized by ROS, muscle force production is diminished (22). Reducing agents such as antioxidants can protect cells against ROS-induced oxidative stress (21). Theoretically, it follows that increasing the intracellular levels of antioxidants within a muscle cell should provide greater protection against these oxidizing agents and reduce fatigue. However, Reid et al. (22) have demonstrated that low levels of ROS are required for optimum muscle contractile function. Specifically, they demonstrated that addition of the antioxidant enzymes (i.e., catalase and superoxide dismutase) resulted in diminished in vitro muscle contractile performance in unfatigued muscle. Further, the addition of strong synthetic antioxidants such as dithiothreitol (3), N-acetylcysteine (NAC) (13), and DMSO (23) to an organ bath containing skeletal muscle also results in depressed skeletal muscle force production. Combined, these studies indicate that administration of synthetic antioxidants may negatively impact skeletal muscle contractile properties in unfatigued muscle. At present, it is unknown whether similar effects occur when antioxidants are consumed in the diet in large quantities; this forms the basis for the current experiments.
Vitamin E (VE) is an important dietary antioxidant in biological
systems because of its association with the cell membrane and its
ability to act directly on ROS and prevent lipid peroxidation (6). After quenching a radical, VE is converted to a
radical (chromanoxyl form) and loses its antioxidant capacity. Recent research has focused on the ability of VE to be reduced from this chromanoxyl form back to its native state via other antioxidants. This
regeneration of VE can be achieved by dihydrolipoic acid (DHLA), the
reduced form of
-lipoic acid (
-LA) (12). In addition to its ability to recycle VE,
-LA is also a potent antioxidant because of its capacity to quench ROS in both the aqueous and lipid
phases of the cell (19). Indeed, the combination of VE and
-LA has been shown to act synergistically to protect cells against
oxidative damage such as ischemia-reperfusion injury, neurodegeneration, and cataract formation (19). Hence, we
selected the combination of the antioxidants VE and
-LA to determine
whether these dietary antioxidants impact skeletal muscle contractile function.
Therefore, the primary purpose of these experiments was to determine
the effects of dietary supplementation with VE and
-LA on skeletal
muscle contractile function in situ. On the basis of previous studies,
we hypothesized that consumption of large quantities of dietary
antioxidants would negatively impact muscle force production in
unfatigued skeletal muscle. Our results supported this hypothesis and
revealed that supplementation with
-LA and VE resulted in a right
shift in the muscle force-frequency curve. These findings prompted a
second series of experiments designed to elucidate whether this right
shift in the force-frequency curve was due to VE or
-LA alone or to
the combination of the two antioxidants. To address this question, we
used the in vitro rat diaphragm preparation and investigated the
effects of these antioxidants both collectively and individually.
| |
METHODS |
|---|
|
|
|---|
In Situ Experiment (Experiment 1)
Female Sprague-Dawley rats (4 mo old, n = 28) were divided into 2 dietary groups: 1) control (Con) and 2) supplemented with VE and
-LA (Antiox). Con animals
were fed an AIN-93M purified diet containing 75 IU/kg diet VE
(DL-
-tocopheryl acetate). The Antiox animals were fed
the AIN-93M purified diet with an additional 10,000 IU/kg diet
DL-
-tocopheryl acetate (Hoffmann-LaRoche, Nutley, NJ)
and 1.65 g/kg
-LA (Asta Medica, Frankfurt, Germany). Animals were
fed their respective diets for 8 wk before the measurement of muscle
contractile properties. Diets were professionally prepared by Harlan
Teklad (Madison, WI). To ensure that all animals consumed equal amounts
of their respective diets, animals were pair fed. This was achieved by
first pairing animals (14 pairs) on the basis of body weight,
allocating one to each group, and housing them individually. In seven
of the pairs, the animal in the Con group was given the weight of food
that the corresponding pair from the Antiox group consumed the previous
day. In the other seven pairs this was reversed so that the animal from
the Antiox group received the weight of food that the corresponding
pair from the Con group consumed the previous day. Weight gain was
equal between groups (data not presented).
On completion of the feeding period, animals were anesthetized with an intraperitoneal injection of pentobarbital sodium (40 mg/kg) and ventilated (tidal volume = 0.7 ml/100 g body mass; breathing frequency = 80 breaths/min and positive end-expiratory pressure = 1.0 cmH2O) with room air using a Columbus small animal ventilator (CIV-101, Columbus, OH) to maintain a constant arterial partial pressure of O2 (PaO2) of ~90 mmHg. PaO2 was determined via blood gas analysis (IL 1610, Instrumentation Laboratories, Lexington, MA) with 75-µl samples taken from the arterial catheter. PaO2 was maintained by increasing the respiratory frequency when necessary.
Rectal temperature was monitored, and body temperature was maintained at 37°C with a heating blanket. After a surgical plane of anesthesia was reached, the sciatic nerve was located and cut, with the distal stump placed in a bipolar electrode. The tendon of the tibialis anterior (TA) muscle was cut close to the bone and attached to an isotonic force transducer (Piezo Systems, Cambridge, MA, model 400). The TA was chosen for the experiment because of its mixed-fiber-type composition. The transducer output was amplified and differentiated by operational amplifiers and underwent analog-to-digital conversion for analysis with a computer-based data acquisition system (GW Instruments-Series II, Somerville, MA).
Muscle temperature and moisture were maintained with a heating lamp and saline-soaked gauze, respectively. The origin of the TA muscle was anchored with a bone nail placed in the femur perpendicular to the limb. Previous experiments in our laboratory indicate that circulation to the muscle was not affected by the procedure (unpublished results). Calibration of the force transducer was done by applying known weights on the lever. The TA was stimulated to contract via stimulation of the sciatic nerve with a Grass Instruments S48 stimulator (Quincy, MA). Twitch measurements were used to determine optimal muscle length (Lo) initially and throughout the experiment. Maximal specific tension (Po), twitch tension (Pt), and a force-frequency curve were then determined at Lo before and after a 60-min fatigue protocol.
Po was measured with a series of isometric tetanic contractions using a supramaximal stimulus train (250 ms, 60 V, and 150 Hz). Each tetanic contraction was separated by a 2-min recovery period to prevent fatigue between contractions. The absolute maximal force was then divided by the wet weight of the TA to obtain Po (N/kg). Pt was measured with a 2-ms twitch contraction at 60 V. The force-frequency curve was determined by stimulating the muscle to contract every 2 min at 10, 20, 30, 40, 60, 80, 120, 160, 200, and 250 Hz (60-V, 250-ms trains). The fatigue protocol consisted of 60-V, 15-Hz trains every 2 s. The duty cycle [ratio of the period of muscle contraction (250 ms) to the duration of a cycle of contraction and rest (2,250 ms)] was 1:9.
Immediately after the contractile measurements, the animal was
euthanized with a lethal injection of pentobarbital sodium (100 mg/kg).
The TA muscle was removed, trimmed of fat and connective tissue,
weighed, frozen in liquid nitrogen, and stored at
80°C for future
biochemical analyses. The contralateral TA was also removed for
comparative biochemical measurements.
Measurement of VE levels in muscle. The concentration of VE in the TA was determined with high-performance liquid chromatography (HPLC) using the protocol of Cort et al. (7). Samples from both the contracted and the contralateral limb were homogenized in acetone using a mechanical homogenizer (Ultra-Turrax T25, IKA Works, Cincinnati, OH). Samples were extracted twice with petroleum ether and then reconstituted in isooctane and analyzed for VE content. The isooctane extract (20 µl) was injected onto a 250 × 4 mm, 10-µm LiChrosorb SI column (Baird and Tatlock, Dagenham, UK).
Measurement of
-LA levels in muscle.
Tissue levels of
-LA were measured according to Panigrahi et al.
(20), with slight modification. Frozen samples
(0.5-0.6 g) were ground to powder in liquid nitrogen with a mortar
and pestle then homogenized on ice in 2 ml of 20% metaphosphoric acid using a Teflon homogenizer. The homogenate was ultrasonicated intermittently for 100 s (10-s periods with 10 s rest). After hexane evaporation under nitrogen, the extract was solubilized in a
solvent containing 50% 0.2 M monochloroacetic acid, 30% acetonitrile, and 20% methanol. Samples were filtered (0.22 µm) and frozen at
80°C for HPLC analysis. Samples (0.2 ml) were separated on a Alltima C18 column (250 × 4.6 mm, 5 µm; Alltech Associates,
Deerfield, IL) using a mobile phase consisting of 50% 50 mM sodium
biphosphate in water, 30% acetonitrile, and 20% methanol and a flow
rate of 1 ml/min.
-LA was detected at a retention time of 9.5 min
using a Coulechem II multielectrode electrochemical detector (ESA model 5100A, ESA, Chelmsford, MA). The electrodes were set at the following potentials: electrode 1, +0.45 V; electrode 2,
+0.85 V; and guard cell: +0.90 V. Racemate mixture of
lipoate (50% DHLA, 50%
-LA), used as a standard, was provided by
ASTA Medica (Frankfurt, Germany). With the use of this method, a linear
(r2 = 0.996) standard curve in the range
0.2-0.75 nM of lipoate was obtained.
Lipid peroxidation measurements. To determine the amount of oxidative damage in the TA, levels of lipid peroxidation were measured by two methods. First, malondialdehyde levels were measured spectrophotometrically using the thiobarbituric acid-reactive substance (TBARS) method described by Mihara and Uchiyama (16). 1,1,3,3-Tetraethoxypropane was used as the standard for this assay. Secondly, lipid hydroperoxides were quantified using the ferrous oxidation/xylenol orange technique described by Hermes-Lima et al. (11). Cumene hydroperoxide was used as the standard for this assay, and hydroperoxide values are expressed in cumene hydroperoxide equivalents (CHE). In our hands, the coefficients of variation for the TBARS and the lipid hydroperoxide assays are ~3 and 4%, respectively.
In Vitro Protocol (Experiment 2)
The TA muscle was not used in our in vitro experiments because the diameter of this muscle is too great to permit gases to diffuse to and from deep fibers in a nonperfused in vitro preparation. Hence, to avoid this problem, we selected the costal diaphragm for study because the diameter of this muscle in the rat is not diffusion limited in an in vitro preparation. Similar to the TA, the costal diaphragm is a mixed-fiber muscle. Importantly, the in vitro rat diaphragm preparation is a well-established model to study skeletal muscle function in vitro (9, 10, 13, 21-23).Four-month-old female Sprague-Dawley rats (n = 32) were anesthetized with an intraperitoneal injection of pentobarbital sodium (90 mg/kg). When the animal reached a surgical plane of anesthesia, the diaphragm was quickly excised with the ribs and central tendon intact and placed in Krebs-Ringer solution (containing in mM: 137 NaCl, 5 KCl, 2 CaCl, 1 MgSO4, 1 NaH2PO4, and 24 NaHCO3) equilibrated with 95% O2-5% CO2 (pH 7.4). Two small strips of muscle (~3.0 × 20-25 mm) from the ventral costal diaphragm were carefully cut with a portion of rib and central tendon retained on each strip to enable the attachment of a clamp without compromising constituent fibers.
Figure 1 illustrates the protocol of
experiment 2. Isometric contractile properties of each strip
were measured simultaneously using a dual-bath setup. Each muscle strip
was suspended vertically between two lightweight Plexiglas clamps in a
100-ml temperature-controlled bath (Harvard Scientific, Holliston, MA).
Each strip was connected to an isometric force transducer (Grass
FT-03D) and mounted on a micrometer for adjustment of muscle length.
The baths contained Krebs-Ringer solution with 25 µM
D-tubocurarine chloride and equilibrated with 95%
O2-5% CO2. Field stimulation was created along
the entire length of each muscle strip with platinum plate electrodes
(4 × 37 mm) using a modified Grass Instruments S48 stimulator
(Quincy, MA). The stimulator was modified to produce sufficient
amperage for field stimulation in both baths simultaneously. Output
from each transducer was amplified and differentiated by operational amplifiers and underwent analog-to-digital conversion for analysis using a computer-based data acquisition system (GW Instruments-Series II).
|
At the beginning of each protocol, the strips were maintained at 25°C to minimize temperature-dependent deterioration. Each strip was adjusted to its Lo by systematically altering the length of the muscle using a micrometer while evoking twitch contractions (140 V, 2-ms duration). Once Lo was established, Po was measured using tetanic contractions (100 Hz, 330 ms, 140 V). Maximal force generation during tetanic contractions was normalized to cross-sectional area (CSA) and expressed as newtons (N/cm2). CSA was estimated using the formula CSA (cm2) = muscle mass (g)/[muscle length (cm) × muscle density (g/cm3)], assuming muscle density = 1.056 g/cm3 (30). Response of the diaphragm muscle strip to increasing stimulus frequency was assessed at Lo, by the application of 20-, 30-, 40-, 60-, 80-, 120-, 160-, and 200-Hz pulses applied in 330-ms trains at 140 V. A 2-min recovery period was used between contractions. At the completion of the force-frequency protocol, the temperature of the muscle bath was increased to 37°C, and either an antioxidant treatment or the vehicle (alcohol) was added to the muscle baths. The following antioxidant treatments were investigated: 1) combination of VE (400 µM) and DHLA (100 µM), 2) VE (400 µM), 3) DHLA (100 µM), 4) VE (200 µM), or 5) VE (100 µM). Each experimental treatment was prepared by adding the compound(s) to 500 µl of alcohol and vortexing in an Eppendorf tube until dissolved. Thirty minutes after the increase in bath temperature and the addition of the aforementioned compound(s) to the baths, Po, Pt, and the force-frequency relationship were assessed. Note that alcohol did not affect contractile properties of the muscle strip in the control bath.
Fatigue of the diaphragm strips was then determined by monitoring the decrease in force development over time. The muscle strips were stimulated simultaneously with tetanic contractions (40 Hz, 250 ms) every 2 s (duty cycle = 1:9). This pattern of stimulation was chosen to elicit a 40-50% reduction in force in 30 min. Fatigue was determined at 37°C because Diaz et al. (9) have shown that antioxidants are more likely to have an effect on diaphragm fatigue resistance in vitro at this temperature.
Data Analysis
Comparisons between groups for each dependent variable were made using either a one-way or two-way (repeated-measures) ANOVA where appropriate. For multiple comparisons, a Bonferroni correction was used. Differences were evaluated via post hoc analysis using a Scheffé's test. Significance was established a priori at P < 0.05.| |
RESULTS |
|---|
|
|
|---|
Experiment 1
Supplementation with VE and
-LA resulted in a significant
increase (P < 0.05) in the VE and lipoate content of
the tibialis anterior (TA) (Fig. 2). In
addition, the contractile protocol was associated with a significant
loss (P < 0.05) of VE from the stimulated muscle only
in supplemented animals.
|
A comparison of the contractile properties of the TA from Con and
Antiox animals before the fatigue protocol is presented in Table
1. Supplementation with VE and
-LA had
no significant effect (P > 0.05) on Po and
the tetanic-twitch ratio (Po/Pt). There was,
however, a significant decrease (P < 0.05) in
Pt in supplemented animals.
|
Figure 3 illustrates the force-frequency
response before and after the fatigue protocol. Before the fatigue
protocol, muscle force production was significantly depressed
(P < 0.05) at stimulation frequencies
40 Hz in
Antiox animals. However, after the fatigue protocol, no group
differences existed (P > 0.05) in force production at
any stimulation frequency.
|
No differences existed (P > 0.05) in TA force
production between Con and Antiox animals throughout the 60-min fatigue
protocol (Fig. 4). Furthermore, no
differences existed (P > 0.05) between groups in
muscle contractile properties after the fatigue protocol (data not
shown).
|
Two markers of lipid peroxidation were used to determine the
effects of the contractile protocol on oxidative damage of the TA in
experiment 1. Figure 5
contains the values for TBARS and CHE in both experimental groups.
Similar results were obtained by using the two markers of lipid
peroxidation. In the Con diet group, the contractile protocol resulted
in a significant increase (P < 0.05) in both TBARS and
CHE levels in the stimulated TA compared with the contralateral muscle.
An important finding was that the stimulated TA from the Antiox animals
had significantly lower (P < 0.05) TBARS and CHE
levels compared with the contracted TA from Con animals.
|
Experiment 2
Table 2 shows the initial contractile measurements from the rat diaphragm in vitro experiment. Addition of VE and DHLA to the preparation did not impact (P > 0.05) Po or Po/Pt.
|
Similar to the in situ experiment, there was a significant decrease
(P < 0.05) in Pt and maximal force
production at frequencies <40 Hz when either the combination of VE
(400 µM) and DHLA (100 µM) or VE (400 µM) was added to the bath
(Fig. 6). Compared with control, no
differences existed in the force-frequency relationship when either
DHLA (100 µM), VE (200 µM) or VE (100 µM) was added to the bath
(data not shown).
|
Finally, there were no differences in (in vitro) muscle fatigue between
control and any of the antioxidant treatments. Figure 7 shows data comparing control with the
combination of VE (400 µM) and DHLA (100 µM). The data for the
other treatments are not shown.
|
| |
DISCUSSION |
|---|
|
|
|---|
Summary of Principal Findings
To our knowledge, this is the first study to examine the effects of dietary supplementation of dietary antioxidants on skeletal muscle contractile function in situ. Our results indicate that 8 wk of supplementation with VE and
-LA significantly increased the levels
of these antioxidants within the TA muscle. Interestingly, although
dietary supplementation with antioxidants reduced the magnitude of
contraction-induced lipid peroxidation in the TA muscle, antioxidant
supplementation did not improve the fatigue resistance of this
muscle during an in situ fatigue protocol. Furthermore, in nonfatigued
muscle, the TA from antioxidant-supplemented animals generated less
tetanic force at stimulation frequencies
40 Hz. On the basis of this
result, we performed a second series of experiments using an in vitro
rat diaphragm preparation to determine which antioxidant was
responsible for this loss of contractile force. When muscle strips were
incubated in either 400 µM of VE alone or a combination of VE (400 µM) and DHLA (100 µM), a reduction in submaximal tetanic force
generation was observed (i.e., right shift in the force-frequency
relationship). However, incubation with DHLA alone (up to 100 µM) or
low levels of VE alone (<200 µM) did not alter the normal
force-frequency relationship. Collectively, these results indicate that
dietary supplementation with high doses of VE can result in a
depression in muscle contractile function at low stimulation frequencies.
Dietary Antioxidants and Muscle Force Production
Again, our results indicate that dietary consumption of high doses of antioxidants impairs muscle force production in situ. This finding supports previous in vitro studies indicating that exogenous antioxidants have a negative effect on skeletal muscle contractile function in unfatigued muscle (9, 13, 22, 23, 25). For example, Reid et al. (22) demonstrated that isolated diaphragm fiber bundles incubated with the antioxidant enzymes catalase and superoxide dismutase display depressed submaximal tetanic contractile force generation. Similarly, investigators have demonstrated that incubation of skeletal muscle with NAC resulted in a depression of submaximal tetanic force production (9, 13). Collectively, the current in situ data and previously published in vivo results indicate that high levels of antioxidants can negatively effect both twitch and submaximal tetanic contractions in unfatigued muscle. Collectively, these observations support the notion that a redox balance must exist for optimal skeletal muscle contractile function.How does redox balance influence muscle force production? The literature indicates that several redox-sensitive skeletal muscle proteins play active roles in the contractile process. For example, the ryanodine-sensitive calcium release channel of the sarcoplasmic reticulum (SR) has multiple sulfhydryl groups that are sensitive to redox modulation by ROS or reactive nitrogen species (1, 24). We postulate that in the present study the antioxidant supplementation led to an increased antioxidant concentration in the SR membranes, leading to a reduction of regulatory sulfhydryls on the calcium release channel. This would result in a redox depression of calcium transients during twitch and low-frequency tetanic stimulation, leading to lower muscle force production. Nonetheless, based on the present data alone, this postulate is conjecture because it is not possible to determine the exact redox mechanism(s) responsible for the impaired muscle force production at low stimulation frequencies. This is an interesting area for future research.
Combined, these data indicate that optimal contractile function depends on the redox state of some or all of the cellular elements that participate in muscular contraction. The present study did not determine the VE content of organelles such as the SR. Nonetheless, given the lipid composition of the SR, it seems likely that both the in vivo supplementation and the in vitro incubation resulted in additional VE availability at the SR membrane; this could have modified redox balance and impacted contractile function. Additional studies are required to determine the molecular mechanisms responsible for the VE interference with muscle force production during submaximal tetanic stimulation.
The observation that dietary supplementation of dietary antioxidants in rats is capable of interfering with skeletal muscle contractile function at low stimulation frequencies may have implications to humans consuming megadoses of antioxidants. Indeed, the dietary levels of VE provided to animals in the current experiments results in blood levels of VE in the rat that are comparable to blood VE levels in humans taking VE doses of 1,000 IU/day (91 ± 6 µm) (29). Nonetheless, whether or not dietary supplementation with high doses of VE would impair human muscle performance is unknown; this is an interesting area for further research.
Dietary Antioxidants and Muscle Fatigue
A number of studies have reported that exogenous antioxidants protect against skeletal muscle fatigue (4, 9, 13, 14, 18, 23, 28, 31). Most of these studies have applied synthetic or enzymatic antioxidants and employed in vitro muscle preparations (4, 9, 13, 23, 28, 31). For example, NAC has been shown to reduce fatigue in both rabbit (28) and rat diaphragms (9, 13). Further, Barclay and Hansel (4) used DMSO to demonstrate that skeletal muscle fatigue can be attenuated with antioxidant administration in both an in vitro mouse soleus model and an in situ canine gastrocnemius-plantaris preparation. These authors concluded that oxidative stress contributes to muscular fatigue.Although dietary antioxidant supplementation attenuated exercise-induced lipid peroxidation in the TA muscle in our experiments, our data indicate that neither the in situ nor in vitro models of muscular fatigue were affected by antioxidant administration. This observation agrees with a number of studies investigating the ergogenic potential of dietary supplementation with antioxidants. In this regard, three studies have concluded that dietary antioxidants do not improve muscular performance (5, 17, 27). However, a recent study has reported a performance benefit of antioxidants. Specifically, Lands et al. (14) used a cysteine donor to augment endogenous glutathione synthesis and reported an improvement in human exercise tolerance during short-duration leg exercise (i.e., isokinetic cycling). Additional research to corroborate these findings at varying exercise intensities and durations is warranted.
Summary and Conclusions
The purpose of these experiments was to determine the effects of the dietary antioxidants VE and
-LA on skeletal muscle contractile function. Our experiments demonstrate that dietary supplementation with
VE and
-LA results in a right shift in the muscle force-frequency relationship. Subsequent experiments using the rat in vitro diaphragm model revealed that the depressed contractility of skeletal muscle at
low stimulation frequencies was due to the effects of VE. Results from
both experiments indicated that these antioxidant supplements had no
effect on skeletal muscle fatigue. We conclude from these observations
that the dietary antioxidant VE, in high doses, has a negative effect
on skeletal muscle function.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: J. S. Coombes, School of Human Movement Studies, Rm. 520 Connell Bldg., Univ. of Queensland, St Lucia, QLD, 4072, Australia (E-mail: jcoombes{at}hms.uq.edu.au).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1 September 2000; accepted in final form 16 November 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aghdasi, B,
Zhang JZ,
Wu Y,
Reid MB,
and
Hamilton SL.
Multiple classes of sulfhydryls modulate the skeletal muscle Ca2+ release channel.
J Biol Chem
272:
3739-3748,
1997
2.
Alessio, HM,
Goldfarb AH,
and
Cao G.
Exercise-induced oxidative stress before and after vitamin C supplementation.
Int J Sport Nutr
7:
1-9,
1997[Web of Science][Medline].
3.
Andrade, FH,
Reid MB,
Allen DG,
and
Westerblad H.
Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse.
J Physiol (Lond)
509 (Pt 2):
565-575,
1998
4.
Barclay, JK,
and
Hansel M.
Free radicals may contribute to oxidative skeletal muscle fatigue.
Can J Physiol Pharmacol
69:
279-284,
1991[Web of Science][Medline].
5.
Brady, PS,
Brady LJ,
and
Ullrey DE.
Selenium, vitamin E and the response to swimming stress in the rat.
J Nutr
109:
1103-1109,
1979.
6.
Burton, GW,
and
Traber MG.
Vitamin E: antioxidant activity, biokinetics, and bioavailability.
Annu Rev Nutr
10:
357-382,
1990[Web of Science][Medline].
7.
Cort, W,
Vicente TS,
Waysek EH,
and
Williams BD.
Vitamin E content of feedstuffs determined by high-performance liquid chromatographic fluorescence.
J Agric Food Chem
31:
1330-1333,
1983[Web of Science][Medline].
8.
Davies, KJ,
Quintanilha AT,
Brooks GA,
and
Packer L.
Free radicals and tissue damage produced by exercise.
Biochem Biophys Res Commun
107:
1198-1205,
1982[Web of Science][Medline].
9.
Diaz, PT,
Brownstein E,
and
Clanton TL.
Effects of N-acetylcysteine on in vitro diaphragm function are temperature dependent.
J Appl Physiol
77:
2434-2439,
1994
10.
Diaz, PT,
She ZW,
Davis WB,
and
Clanton TL.
Hydroxylation of salicylate by the in vitro diaphragm: evidence for hydroxyl radical production during fatigue.
J Appl Physiol
75:
540-545,
1993
11.
Hermes-Lima, M,
Willmore WG,
and
Storey KB.
Quantification of lipid peroxidation in tissue extracts based on Fe(III) xylenol orange complex formation.
Free Radic Biol Med
19:
271-280,
1995[Web of Science][Medline].
12.
Kagan, VE,
Serbinova EA,
Forte T,
Scita G,
and
Packer L.
Recycling of vitamin E in human low density lipoproteins.
J Lipid Res
33:
385-397,
1992[Abstract].
13.
Khawli, FA,
and
Reid MB.
N-acetylcysteine depresses contractile function and inhibits fatigue of diaphragm in vitro.
J Appl Physiol
77:
317-324,
1994
14.
Lands, LC,
Grey VL,
and
Smountas AA.
Effect of supplementation with a cysteine donor on muscular performance.
J Appl Physiol
87:
1381-1385,
1999
15.
Meydani, M,
Evans W,
Handelman G,
Fielding RA,
Meydani SN,
Fiatarone MA,
Blumberg JB,
and
Cannon JG.
Antioxidant response to exercise-induced oxidative stress and protection by vitamin E.
Ann NY Acad Sci
669:
363-364,
1992[Web of Science][Medline].
16.
Mihara, M,
and
Uchiyama M.
Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.
Anal Biochem
86:
271-278,
1978[Web of Science][Medline].
17.
Nielsen, AN,
Mizuno M,
Ratkevicius A,
Mohr T,
Rohde M,
Mortensen SA,
and
Quistorff B.
No effect of antioxidant supplementation in triathletes on maximal oxygen uptake, 31P-NMRS detected muscle energy metabolism and muscle fatigue.
Int J Sports Med
20:
154-158,
1999[Web of Science][Medline].
18.
Novelli, GP,
Bracciotti G,
and
Falsini S.
Spin-trappers and vitamin E prolong endurance to muscle fatigue in mice.
Free Radic Biol Med
8:
9-13,
1990[Web of Science][Medline].
19.
Packer, L,
Witt EH,
and
Tritschler HJ.
-Lipoic acid as a biological antioxidant.
Free Radic Biol Med
19:
227-250,
1995[Web of Science][Medline].
20.
Panigrahi, M,
Sadguna Y,
Shivakumar BR,
Kolluri SV,
Roy S,
Packer L,
and
Ravindranath V.
-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats.
Brain Res
717:
184-188,
1996[Web of Science][Medline].
21.
Reid, MB,
Haack KE,
Franchek KM,
Valberg PA,
Kobzik L,
and
West MS.
Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro.
J Appl Physiol
73:
1797-1804,
1992
22.
Reid, MB,
Khawli FA,
and
Moody MR.
Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle.
J Appl Physiol
75:
1081-1087,
1993
23.
Reid, MB,
and
Moody MR.
Dimethyl sulfoxide depresses skeletal muscle contractility.
J Appl Physiol
76:
2186-2190,
1994
24.
Salama, G,
Abramson JJ,
and
Pike GK.
Sulphydryl reagents trigger Ca2+ release from the sarcoplasmic reticulum of skinned rabbit psoas fibres.
J Physiol (Lond)
454:
389-420,
1992
25.
Sams, WM, Jr,
Carroll NV,
and
Crantz PL.
Effect of dimethylsulfoxide on isolated-innervated skeletal, smooth, and cardiac muscle.
Proc Soc Exp Biol Med
122:
103-107,
1966[Medline].
26.
Sen, CK,
Atalay M,
Agren J,
Laaksonen DE,
Roy S,
and
Hänninen O.
Fish oil and vitamin E supplementation in oxidative stress at rest and after physical exercise.
J Appl Physiol
83:
189-195,
1997
27.
Sharman, IM,
Down MG,
and
Sen RN.
The effects of vitamin E and training on physiological function and athletic performance in adolescent swimmers.
Br J Nutr
26:
265-276,
1971[Web of Science][Medline].
28.
Shindoh, C,
DiMarco A,
Thomas A,
Manubay P,
and
Supinski G.
Effect of N-acetylcysteine on diaphragm fatigue.
J Appl Physiol
68:
2107-2113,
1990
29.
Simons, LA,
von Konigsmark M,
Simons J,
Stocker R,
and
Celermajer DS.
Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults.
Atherosclerosis
143:
193-199,
1999[Web of Science][Medline].
30.
Taylor, JA,
and
Kandarian SC.
Advantage of normalizing force production to myofibrillar protein in skeletal muscle cross-sectional area.
J Appl Physiol
76:
974-978,
1994
31.
Travaline, JM,
Sudarshan S,
Roy BG,
Cordova F,
Leyenson V,
and
Criner GJ.
Effect of N-acetylcysteine on human diaphragm strength and fatigability.
Am J Respir Crit Care Med
156:
1567-1571,
1997
32.
Witt, EH,
Reznick AZ,
Viguie CA,
Starke-Reed P,
and
Packer L.
Exercise, oxidative damage and effects of antioxidant manipulation.
J Nutr
122:
766-773,
1992.
This article has been cited by other articles:
![]() |
S. W. Copp, L. F. Ferreira, K. F. Herspring, D. M. Hirai, B. S. Snyder, D. C. Poole, and T. I. Musch The effects of antioxidants on microvascular oxygenation and blood flow in skeletal muscle of young rats Exp Physiol, September 1, 2009; 94(9): 961 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Powers and M. J. Jackson Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production Physiol Rev, October 1, 2008; 88(4): 1243 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Ferreira and M. B. Reid Muscle-derived ROS and thiol regulation in muscle fatigue J Appl Physiol, March 1, 2008; 104(3): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Gomez-Cabrera, E. Domenech, M. Romagnoli, A. Arduini, C. Borras, F. V Pallardo, J. Sastre, and J. Vina Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance Am. J. Clinical Nutrition, January 1, 2008; 87(1): 142 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Lennon, J. C. Quindry, K. L. Hamilton, J. P. French, J. Hughes, J. L. Mehta, and S. K. Powers Elevated MnSOD is not required for exercise-induced cardioprotection against myocardial stunning Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H975 - H980. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Marshall, K. C. Scott, R. C. Hill, D. D. Lewis, D. Sundstrom, G. L. Jones, and J. Harper Supplemental Vitamin C Appears to Slow Racing Greyhounds J. Nutr., June 1, 2002; 132(6): 1616S - 1621. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |